​

Amylyx Pharmaceuticals (AMLX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Amylyx Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$87.37M

Latest Revenue (Q)

$416.00K

Amylyx Pharmaceuticals Revenue by Period

Amylyx Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$87.37M-77.06%
2023-12-31$380.79M1612.94%
2022-12-31$22.23M7700.00%
2021-12-31$285.00K-56.15%
2020-12-31$650.00K-54.42%
2019-12-31$1.43M-

Amylyx Pharmaceuticals generated $87.37M in revenue during NA 2024, up -77.06% compared to the previous quarter, and up 6127.00% compared to the same period a year ago.

Amylyx Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30$416.00K-140.66%
2024-06-30$-1.02M-101.15%
2024-03-31$88.64M-18.26%
2023-12-31$108.45M5.61%
2023-09-30$102.69M4.56%
2023-06-30$98.22M37.50%
2023-03-31$71.43M226.38%
2022-12-31$21.89M6243.48%
2022-09-30$345.00K100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31--100.00%
2021-09-30$285.00K100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$350.00K-

Amylyx Pharmaceuticals generated $416.00K in revenue during Q3 2024, up -140.66% compared to the previous quarter, and up 0.42% compared to the same period a year ago.

Amylyx Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
DAWNDay One Biopharmaceuticals$131.16M$20.07M
AMLXAmylyx Pharmaceuticals$87.37M$416.00K
XFORX4 Pharmaceuticals$2.56M$560.00K
PDSBPDS Bio--
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
HOOKHOOKIPA Pharma-$4.70M
MREOMereo BioPharma Group--

AMLX Revenue FAQ

What is Amylyx Pharmaceuticals’s yearly revenue?

Amylyx Pharmaceuticals's yearly revenue for 2024 was $87.37M, representing a decrease of -77.06% compared to 2023. The company's yearly revenue for 2023 was $380.79M, representing an increase of 1612.94% compared to 2022. AMLX's yearly revenue for 2022 was $22.23M, representing an increase of 7700.00% compared to 2021.

What is Amylyx Pharmaceuticals’s quarterly revenue?

Amylyx Pharmaceuticals's quarterly revenue for Q3 2024 was $416K, a -140.66% decrease from the previous quarter (Q2 2024), and a -99.59% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $-1.023M, a -101.15% decrease from the previous quarter (Q1 2024), and a -101.04% decrease year-over-year (Q2 2023). AMLX's quarterly revenue for Q1 2024 was $88.64M, a -18.26% decrease from the previous quarter (Q4 2023), and a 24.10% increase year-over-year (Q1 2023).

What is Amylyx Pharmaceuticals’s revenue growth rate?

Amylyx Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 293.03%, and for the last 5 years (2020-2024) was 13341.69%.